Vertex Pharmaceuticals (VRTX) Current Deferred Revenue (2009 - 2017)
Vertex Pharmaceuticals (VRTX) recorded Current Deferred Revenue of $5.17 million in Q4 2017, down 13.9% from $6.01 million a year earlier and down 60.2% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Current Deferred Revenue (2009 - 2017) Analysis & Trends
Starting with Q4 2009, Vertex Pharmaceuticals' Current Deferred Revenue history includes 32 quarters.
- Annual Current Deferred Revenue has declined for eight straight years, with a five-year compound annual growth rate of -28.5% (FY2012 to FY2017).
- Across earlier years, Current Deferred Revenue came in at $6.01 million in FY2016 (-63.2%), $16.3 million in FY2015 (-6.7%), $17.47 million in FY2014 (-18.8%) and $21.51 million in FY2013 (-22.0%).
- The Q4 2017 figure is the lowest quarterly Current Deferred Revenue in data going back to Q4 2009.
- On a year-over-year basis, Current Deferred Revenue rose in 1 of the last eight quarters, with an average decline of 24.6%.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 40.6% in Q3 2017, against a decline of 63.2% in Q4 2016 at the low end.
- Per Business Quant, the preceding three quarters came in at $13 million (Q3 2017), $7.28 million (Q2 2017) and $6.06 million (Q1 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 5.17 Mn |
| Sep 30, 2017 | 13.00 Mn |
| Jun 30, 2017 | 7.28 Mn |
| Mar 31, 2017 | 6.06 Mn |
| Dec 31, 2016 | 6.01 Mn |
| Sep 30, 2016 | 9.25 Mn |
| Jun 30, 2016 | 11.47 Mn |
| Mar 31, 2016 | 14.71 Mn |
| Dec 31, 2015 | 16.30 Mn |
| Sep 30, 2015 | 14.00 Mn |
| Jun 30, 2015 | 14.93 Mn |
| Mar 31, 2015 | 15.92 Mn |
| Dec 31, 2014 | 17.47 Mn |
| Sep 30, 2014 | 21.21 Mn |
| Jun 30, 2014 | 27.17 Mn |
| Mar 31, 2014 | 28.84 Mn |
| Dec 31, 2013 | 21.51 Mn |
| Sep 30, 2013 | 31.01 Mn |
| Jun 30, 2013 | 32.90 Mn |
| Mar 31, 2013 | 35.53 Mn |
API Access
Vertex Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();